Source:http://linkedlifedata.com/resource/pubmed/id/17727841
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2007-10-30
|
pubmed:abstractText |
Heparin affin regulatory peptide (HARP) is an 18 kDa heparin-binding protein that plays a key role in tumor growth. We showed previously that the synthetic peptide P(111-136) composed of the last 26 HARP amino acids inhibited HARP-induced mitogenesis. Here, to identify the exact molecular domain involved in HARP inhibition, we investigated the effect of the shorter basic peptide P(122-131) on DU145 cells, which express HARP and its receptor protein tyrosine phosphatase beta/zeta (RPTPbeta/zeta). P(122-131) was not cytotoxic; it dose-dependently inhibited anchorage-independent growth of DU145 cells. Binding studies using biotinylated P(122-131) indicated that this peptide interfered with HARP binding to DU145 cells. Investigation of the mechanisms involved suggested interference, under anchorage-independent conditions, of P(122-131) with a HARP autocrine loop in an RPTPbeta/zeta-dependent fashion. Thus, P(122-131) may hold potential for the treatment of disorders involving RPTPbeta/zeta.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-4827
|
pubmed:author |
pubmed-author:BermekOyaO,
pubmed-author:BurlinaFabienneF,
pubmed-author:ChassaingGerardG,
pubmed-author:CourtyJoséJ,
pubmed-author:DelbéJeanJ,
pubmed-author:DiamantopoulouZoiZ,
pubmed-author:EngPeterP,
pubmed-author:FernigDavid GDG,
pubmed-author:Hamma-KourbaliYaminaY,
pubmed-author:KatsorisPagnagiotisP,
pubmed-author:PolykratisApostolisA
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
313
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4041-50
|
pubmed:meshHeading |
pubmed-meshheading:17727841-Cell Division,
pubmed-meshheading:17727841-Cell Line, Tumor,
pubmed-meshheading:17727841-DNA Helicases,
pubmed-meshheading:17727841-Dose-Response Relationship, Drug,
pubmed-meshheading:17727841-Humans,
pubmed-meshheading:17727841-Male,
pubmed-meshheading:17727841-Peptide Fragments,
pubmed-meshheading:17727841-Prostatic Neoplasms,
pubmed-meshheading:17727841-Protein Binding,
pubmed-meshheading:17727841-Receptor-Like Protein Tyrosine Phosphatases, Class 5
|
pubmed:year |
2007
|
pubmed:articleTitle |
A basic peptide derived from the HARP C-terminus inhibits anchorage-independent growth of DU145 prostate cancer cells.
|
pubmed:affiliation |
Laboratoire de recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires (CRRET), CNRS UMR 7149, Université Paris 12, 61 Avenue du Général de Gaulle, 94010 Créteil Cedex, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|